Figure 3.
Time profiles of changes in glycated hemoglobin (HbA 1c; mean ± SD) in the alogliptin 12.5 and 25 mg groups during the course of the 52‐week clinical study (the period in which placebo was given is excluded).
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.